21 March 2019 - - French biotechnology company Transgene (Euronext Paris: TNG) (PAR: TNG) has secured a EUR 20m revolving credit facility with Natixis, the French Corporate and Investment bank, the company said.

The credit facility will ...
21 March 2019 - - Updated results from the cervical cancer cohort of SUMMIT, an ongoing Phase II basket trial examining the efficacy of neratinib in HER2-mutated cancers, were reported at the Society of Gynecologic Oncology 2019 annual meeting in Hon...
21 March 2019 - - The US Food and Drug Administration approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of adults with extensive-stage small cell lung cancer (...
21 March 2019 - Global healthcare company Novo Nordisk A/S (CPH:NOVOB) announced on Wednesday the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral semaglutide, a once-daily glucagon-like peptide-1 (...
21 March 2019 - - German drugmaker Boehringer Ingelheim has filed for regulatory approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) with the FDA and EMA, the company said.

Nintedanib...